A recent study indicates that patients who discontinue blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Research printed in a prominent medical journal points out that while overweight people often shed a large proportion of their body weight while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month once they quit.
"Users buying these drugs should be informed of the risk of quick weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.
That rate of recovery suggests a reversion to original mass within about a year and a half.
Analyzing Treatments
The study, which looked at 37 of studies involving thousands of patients, contrasted the results of the injectable medications with older methods.
Researchers note that individuals who lose weight through diet and exercise usually experience a less rapid weight regain—around 0.1 kg a month—post-intervention.
The Reason for the Rapid Regain
Nutrition scientists believe the mechanism of the jabs explains the heightened regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels far above than normal could lead to the system to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication leads to appetite is unsuppressed, making excessive eating much more probable."
A Chronic Disease?
The NHS suggest the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Many experts contend that, due to the likelihood of relapse, the therapy might need to be long-term.
This view is echoed by drug manufacturers, who say that the findings "underscore the chronic character of obesity," akin to managing diseases like hypertension.
Patient Testimonies
Users who have discontinued the jabs explain a intense return of cravings.
"I experienced something that goes on and you become starving," said one woman.
This difficulty is exacerbated if patients have not developed permanent lifestyle or habit changes during therapy.
Widespread Adoption
Survey data indicate that millions of adults in the UK have tried these injections in the last 12 months, with desire being substantial.
- Adoption is greater among females than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, experts emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a standalone solution and lasting health benefits likely depends on integrated lifestyle support.
